https://www.selleckchem.com/pr....oducts/combretastati
As NF-κB activation in PDAC cells confers resistance to gemcitabine, the AS-10 combination with gemcitabine increased the in vitro cytotoxicity more than the additivity of both compounds. Overall, our results suggest AS-10 may be a promising drug lead for PDAC, both as a single agent and in combination therapy.Digital control for high switching frequency converter enables new features on DC-DC power conversion for a minimum cost. Frequency response identification is one such enabled functionality used in auto tunning, measurem
Like
Comment
Share
